Lysine 473 Regulates the Progression of SLC7A11, the Cystine/Glutamate Exchanger, through the Secretory Pathway

被引:0
|
作者
Koppin, Anna [1 ,2 ]
Chase, Leah [3 ,4 ]
机构
[1] Hope Coll, Dept Biol, Holland, MI 49423 USA
[2] Hope Coll, Dept Chem, Holland, MI 49423 USA
[3] Hope Coll, Dept Biol, Neurosci Program, Holland, MI 49423 USA
[4] Hope Coll, Dept Chem, Neurosci Program, Holland, MI 49423 USA
关键词
xCT; System x(c)(-); endoplasmic reticulum acetylation; trafficking; glycosylation; ANTIPORTER SYSTEM X(C)(-); PROTEIN-KINASE-C; N-GLYCOSYLATION; MECHANISMS; TRAFFICKING; TRANSPORTER; EXPRESSION; PHOSPHORYLATION; ACETYLATION; METABOLISM;
D O I
10.3390/ijms251910271
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
System xc(-), the cystine/glutamate exchanger, is a membrane transporter that plays a critical role in the antioxidant response of cells. Recent work has shown that System xc(-) localizes to the plasma membrane during oxidative stress, allowing for increased activity to support the production of glutathione. In this study, we used site-directed mutagenesis to examine the role of C-terminal lysine residues (K422, K472, and K473) of xCT (SLC7A11) in regulating System xc(-). We observed that K473R exhibits loss of transporter activity and membrane localization and is 7.5 kD lower in molecular weight, suggesting that K473 regulates System xc- trafficking and is modified under basal conditions. After ruling out ubiquitination and neddylation, we demonstrated that unlike WT xCT, K473R lacks N- and O-glycosylation and is sequestered in the endoplasmic reticulum. Next, we demonstrated that K473Q, a constitutively acetylated lysine mimic, also exhibits loss of transporter activity, decreased membrane expression, and a 4 kD decrease in molecular weight; however, it is N- and O-glycosylated and localized to the endoplasmic reticulum and Golgi. These results suggest that acetylation and deacetylation of K473 in the endoplasmic reticulum and Golgi, respectively, serve to regulate the progression of the transporter through the biosynthetic pathway.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] High expression of cystine–glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma
    Mai Froberg Sørensen
    Sólborg Berglind Heimisdóttir
    Mia Dahl Sørensen
    Casper Schau Mellegaard
    Helle Wohlleben
    Bjarne Winther Kristensen
    Christoph Patrick Beier
    Journal of Neuro-Oncology, 2018, 138 : 49 - 53
  • [22] The clinical significance of glutamate/cystine antiporter SLC7A11/xCT in non-small cell lung cancer
    Liu, Dage
    Nakashima, Nariyasu
    Nakano, Takayuki
    Zhang, Xia
    Yokomise, Hiroyasu
    CANCER SCIENCE, 2018, 109 : 1425 - 1425
  • [23] Expression of cysteine/glutamate exchanger (SLC7A11) in different tissues including intestinal segments of broiler chickens
    Choi, J.
    Li, W.
    Schindell, B.
    Ni, L.
    Liu, S.
    Gong, J.
    Nyachoti, C.
    Yang, C.
    JOURNAL OF ANIMAL SCIENCE, 2018, 96 : 185 - 186
  • [24] Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection
    Banerjee, Shreya
    Sarkar, Rakesh
    Mukherjee, Arpita
    Mitra, Suvrotoa
    Gope, Animesh
    Chawla-Sarkar, Mamta
    VIRUS RESEARCH, 2024, 339
  • [25] Ursodeoxycholic acid inhibits the uptake of cystine through SLC7A11 and impairs de novo synthesis of glutathione
    Xie, Fu'an
    Niu, Yujia
    Chen, Xiaobing
    Kong, Xu
    Yan, Guangting
    Zhuang, Aobo
    Li, Xi
    Lian, Lanlan
    Qin, Dongmei
    Zhang, Quan
    Zhang, Ruyi
    Yang, Kunrong
    Xia, Xiaogang
    Chen, Kun
    Xiao, Mengmeng
    Yang, Chunkang
    Wu, Ting
    Shen, Ye
    Yu, Chundong
    Luo, Chenghua
    Lin, Shu-Hai
    Li, Wengang
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2025, 15 (01)
  • [26] Hydrophobicity causes anomalous migration of cystine/glutamate antiporter SLC7A11 in SDS-PAGE with low acrylamide concentration
    Emmanuel, Nsengiyumva
    He, Qian
    Kang, Yixin
    Zhang, Dianbao
    Gao, Min
    Wang, Minglin
    Fan, Kexin
    Xiong, Jingwen
    Wu, Shaobo
    Fa, Botao
    Xiao, Zhengtao
    Niu, Yingfang
    Yao, Jun
    Zhang, Yilei
    FEBS OPEN BIO, 2025,
  • [27] High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma
    Sorensen, Mai Froberg
    Heimisdottir, Solborg Berglind
    Sorensen, Mia Dahl
    Mellegaard, Casper Schau
    Wohlleben, Helle
    Kristensen, Bjarne Winther
    Beier, Christoph Patrick
    JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (01) : 49 - 53
  • [28] HIGH EXPRESSION OF CYSTINE-GLUTAMATE ANTIPORTER XCT (SLC7A11) IS AN INDEPENDENT BIOMARKER FOR EPILEPTIC SEIZURES AT DIAGNOSIS IN GLIOMA
    Beier, C. P.
    Heimisdottir, S. B.
    Soerensen, M. F.
    Wohlleben, H.
    Kristensen, B. W.
    EPILEPSIA, 2017, 58 : S24 - S24
  • [29] Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin
    Liu, Ruqing
    Blower, Paul E.
    Pham, Anh-Nhan
    Fang, Jialong
    Dai, Zunyan
    Wise, Carolyn
    Green, Bridgette
    Teitel, Candee H.
    Ning, Baitang
    Ling, Wenhua
    Lyn-Cook, Beverly D.
    Kadlubar, Fred F.
    Sadee, Wolfgang
    Huang, Ying
    MOLECULAR PHARMACOLOGY, 2007, 72 (06) : 1637 - 1646
  • [30] CIC reduces xCT/SLC7A11 expression and glutamate release in glioma
    Park, Jong-Whi
    Kilic, Omer
    Deo, Minh
    Jimenez-Cowell, Kevin
    Demirdizen, Engin
    Kim, Hyunggee
    Turcan, Sevin
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)